Venetoclax and Voriconazole: Drug Interaction Guide
Quick answer: This is a major interaction — avoid combining Venetoclax and Voriconazole unless specifically directed by your doctor.
How Venetoclax interacts with Voriconazole
Voriconazole strongly inhibits CYP3A4, substantially increasing venetoclax exposure and the risks of tumor lysis syndrome and hematologic toxicity.
What you should do
Avoid voriconazole during venetoclax initiation and dose ramp-up when contraindicated by the treatment protocol. If coadministration is unavoidable outside that period, apply the indication-specific venetoclax dose reduction and monitor closely.
Key facts
Severity
Major — avoid combination
Mechanism
Voriconazole strongly inhibits CYP3A4, substantially increasing venetoclax exposure and the risks of tumor lysis syndrom...
Action
Avoid voriconazole during venetoclax initiation and dose ramp-up when contraindicated by the treatment protocol. If coad...
Frequently asked questions
Can I take Venetoclax and Voriconazole together?
No — this combination should generally be avoided. Avoid voriconazole during venetoclax initiation and dose ramp-up when contraindicated by the treatment protocol. If coadministration is unavoidable outside that period, apply the indication-specific venetoclax dose reduction and monitor closely.
What is the severity of this interaction?
The interaction between Venetoclax and Voriconazole is classified as Major — avoid combination. Voriconazole strongly inhibits CYP3A4, substantially increasing venetoclax exposure and the risks of tumor lysis syndrome and hematologic toxicity.
What should I do if I'm prescribed both?
Avoid voriconazole during venetoclax initiation and dose ramp-up when contraindicated by the treatment protocol. If coadministration is unavoidable outside that period, apply the indication-specific venetoclax dose reduction and monitor closely. Always consult your prescribing clinician — do not stop or change medications without medical guidance.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.